Jennifer Bath | President & CEO |
Brad McConn | CFO |
Ilse Roodink | Chief Scientific Officer |
Barry Duplantis | VP, Client Relations |
Good morning, and thank you for standing by. Welcome to ImmunoPrecise Antibodies First Quarter Fiscal 2022 Earnings Conference Call. Also on the call with us today are Jennifer Bath, Chief Executive Officer; Brad McConn, Chief Financial Officer; Ilse Roodink, Chief Scientific Officer; and Barry Duplantis, Vice President of Client Relations Before we get started, remember, some statements we make today, may be considered forward-looking statements for the purpose of applicable United States and Canadian securities laws. IPA cautions that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.
Additional information about these risks and uncertainties is included in our SEC filings.